Stay updated with breaking news from Doudna Lab. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Mammoth’s proprietary ultracompact CRISPR-based gene editing platform and Regeneron’s proprietary delivery technologies set to advance in vivo programs in multiple tissue and cell types
Mammoth’s proprietary ultracompact CRISPR-based gene editing platform and Regeneron’s proprietary delivery technologies set to advance in vivo programs in multiple tissue and cell types Mammoth...
Benjamin Oakes' Scribe Therapeutics is developing specialized Crispr proteins for multiple diseases–and it’s got deals with Big Pharma potentially worth over $4 billion
On Monday, scientists at UC Berkeley's Doudna Lab published research on a new system for targeting RNA sequences using clustered regularly interspaced short palindromic repeats, or CRISPR, an adaptive immune system present in bacteria, paving the way for additional research and potential medical use.
Researchers at UC Berkeley and UCSF’s Innovative Genomics Institute, or IGI, have found the diversity of CRISPR gene editors in viruses goes far beyond what they expected, possibly leading to new ways of editing genomes.